Now Reading
SEHA’s new field clinic in Abu Dhabi to accept walk-in registrations for Covid-19 vaccine volunteers

SEHA’s new field clinic in Abu Dhabi to accept walk-in registrations for Covid-19 vaccine volunteers

Health authorities in the UAE have issued a permit for up to 15,000 volunteers to take part in the Phase III trials

SEHA ADNEC Abu Dhabi Covid-19 Vaccine

The Department of Health Abu Dhabi in collaboration with G42 Healthcare and Abu Dhabi Health Services (SEHA) have opened a new field clinic at ADNEC to facilitate the Phase III Covid-19 vaccine trials that are underway within the country.

The new facility will accept walk-in registrations and will also serve as a testing facility for volunteers who want to participate in the world’s first clinical Phase III trial of an inactivated vaccine for Covid-19, reported news agency WAM.

The trials are open to healthy volunteers who are residents of Abu Dhabi and aged between 18-60.

The testing period will extend between six to eight months, with volunteers required to be available for follow ups during this time.

The field clinic is able to accommodate 1,000 volunteers per day.

Those who wish to volunteer can visit the clinic without prior appointment or registration, seven days a week from 8am-8pm.

Volunteers will receive on-site Covid-19 screening. The first vaccination will be administered to those who are eligible three days after they test negative for Covid-19.

The Phase III trials commenced on July 16 with Sheikh Abdullah bin Mohammed Al Hamed, chairman of the Department of Health – Abu Dhabi (DOH), becoming the very first volunteer.

Read: Head of Abu Dhabi’s health department becomes first volunteer for Covid-19 Phase III vaccine trials

The trials are being conducted as a partnership between Abu Dhabi based G42 Healthcare, and Sinopharm CNBG, the world’s sixth largest vaccine manufacturer.

Health authorities in the UAE have issued a permit for up to 15,000 volunteers to take part in the trials.

The phase III clinical trial follows the success of the phase I and phase II trials conducted by Sinopharm in China, which resulted in 100 per cent of the volunteers generating antibodies after two doses in 28 days.
The Abu Dhabi Media Office added that further details about the volunteer registration programme can be found online at 4humanity.ae

You might also like

© 2020 MOTIVATE MEDIA GROUP. ALL RIGHTS RESERVED.

Scroll To Top